Clinical Presentation and Treatment Outcomes of Children and Adolescents With Pheochromocytoma and Paraganglioma in a Single Center in Korea
- PMID: 33584544
- PMCID: PMC7879705
- DOI: 10.3389/fendo.2020.610746
Clinical Presentation and Treatment Outcomes of Children and Adolescents With Pheochromocytoma and Paraganglioma in a Single Center in Korea
Abstract
Purpose: Pheochromocytoma (PCC) and paraganglioma (PGL) (PPGL) are rare neuroendocrine tumors, and data on managing these conditions in children and adolescents are lacking. The objective of this study was to demonstrate the clinical presentation and treatment outcomes in children and adolescents with PPGL in a single tertiary care center in Korea.
Methods: This retrospective study included 23 patients diagnosed with PCC (n = 14) and PGL (n = 9) before the age of 21 at Samsung Medical Center (from June 1994 to June 2019). We describe age, gender, family history, clinical characteristics, laboratory findings, pathologic findings, therapeutic approaches, and treatment outcomes.
Results: Of the 23 patients, 14 had PCC and nine had PGL. The median age at diagnosis was 16.8 years (range, 6.8-20.8 years). The common presenting symptoms were hypertension (n = 10), headache (n = 9), palpitation (n = 4), and sweating (n = 4). The plasma or 24-hour urine catecholamine and/or metabolite concentrations were markedly elevated in 22 patients with PPGL, but were normal in one patient with carotid body PGL. All tumors were visualized on computed tomography. Genetic tests were performed in 15 patients, and seven patients showed mutations in RET (n = 3), SDHB (n = 3), and VHL (n = 1). All patients underwent surgery, and complete excision was performed successfully. Three patients with metastasis underwent postoperative adjuvant therapy.
Conclusion: This study suggests that pediatric PPGL tends to be extra-adrenal and bilateral and shows a higher potential for genetic mutations. Considering the hereditary predisposition of pediatric PPGL, genetic screening tests are strongly recommended, and lifelong follow-up is needed to detect recurrence and metastasis. Further research with a larger sample size and routine genetic screening is needed to better understand the genetic conditions and long-term prognosis of PPGL.
Keywords: adrenal mass; hypertension; paraganglioma; pediatrics; pheochromocytoma.
Copyright © 2021 Park, Kim, Lee, Kim, Jeong, Lee, Lee, Cho and Jin.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Genetic Analysis and Clinical Characteristics of Hereditary Pheochromocytoma and Paraganglioma Syndrome in Korean Population.Endocrinol Metab (Seoul). 2020 Dec;35(4):858-872. doi: 10.3803/EnM.2020.683. Epub 2020 Dec 23. Endocrinol Metab (Seoul). 2020. PMID: 33397040 Free PMC article.
-
Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters.J Nucl Med. 2015 Jun;56(6):839-46. doi: 10.2967/jnumed.115.154815. Epub 2015 Apr 16. J Nucl Med. 2015. PMID: 25883126
-
Genetic status determines 18 F-FDG uptake in pheochromocytoma/paraganglioma.J Med Imaging Radiat Oncol. 2017 Dec;61(6):745-752. doi: 10.1111/1754-9485.12620. Epub 2017 Jun 5. J Med Imaging Radiat Oncol. 2017. PMID: 28585398
-
Molecular imaging and theranostic approaches in pheochromocytoma and paraganglioma.Cell Tissue Res. 2018 May;372(2):393-401. doi: 10.1007/s00441-018-2791-4. Epub 2018 Feb 15. Cell Tissue Res. 2018. PMID: 29450723 Free PMC article. Review.
-
Succinate-Dehydrogenase Deficient Paragangliomas/Pheochromocytomas: Genetics, Clinical Aspects and Mini- Review.Pediatr Endocrinol Rev. 2017 Mar;14(3):312-325. doi: 10.17458/per.vol14.2017.RK.succinatedehydrogenase. Pediatr Endocrinol Rev. 2017. PMID: 28508602 Review. No abstract available.
Cited by
-
Perioperative Blood Pressure Management Recommendations in Pediatric Pheochromocytoma: A 10-Year Narrative Review.Kidney Blood Press Res. 2025;50(1):61-82. doi: 10.1159/000542897. Epub 2024 Dec 3. Kidney Blood Press Res. 2025. PMID: 39626645 Free PMC article. Review.
-
[Preclinical diagnostics of von Hippel-Lindau syndrome in a child].Probl Endokrinol (Mosk). 2024 Feb 28;70(1):100-104. doi: 10.14341/probl13280. Probl Endokrinol (Mosk). 2024. PMID: 38433546 Free PMC article. Russian.
-
Current Strategies for Managing Pheochromocytoma and Paraganglioma in Children and Adolescents.Med Sci Monit. 2025 Apr 3;31:e947277. doi: 10.12659/MSM.947277. Med Sci Monit. 2025. PMID: 40176333 Free PMC article. Review.
-
Computed tomography-guided percutaneous cryoablation of hereditary adrenal pheochromocytoma in three patients.J Pediatr Endocrinol Metab. 2024 May 30;37(7):657-662. doi: 10.1515/jpem-2024-0033. Print 2024 Jul 26. J Pediatr Endocrinol Metab. 2024. PMID: 38807486
-
Diaphoresis as the Prominent Manifestation of Pheochromocytoma.AACE Clin Case Rep. 2021 Jul 16;8(1):34-36. doi: 10.1016/j.aace.2021.07.003. eCollection 2022 Jan-Feb. AACE Clin Case Rep. 2021. PMID: 35097200 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical